GLP-1 Makers See Wave of Litigation as Drug Popularity Surges

The drugs that reshaped the weight-loss market may be reshaping the federal docket.  Novo Nordisk and Eli Lilly are known as the two most prominent manufacturers of GLP-1 drugs, which have transformed weight loss in recent years. More than 3,000 pharmaceutical product liability suits have been filed against...

GLP-1 Makers See Wave of Litigation as Drug Popularity Surges

The drugs that reshaped the weight-loss market may be reshaping the federal docket.  Novo Nordisk and Eli Lilly are known as the two most prominent manufacturers of GLP-1 drugs, which have transformed weight loss in recent years. More than 3,000 pharmaceutical product liability suits have been filed against...
spot_img

M&A

Analytics

Emerging Litigation Podcast

IP Protection, Secure Transactions, and Bored Apes: NFTs with Cameron Pick

NFTs – or non-fungible tokens – have taken the digital world by storm – or perhaps just a downloadable picture of a storm – promising to revolutionize not only the way we perceive, protect, purchase, and own digital assets,...

Around Law Street

spot_imgspot_imgspot_imgspot_img

Cryptocurrency

FOIA